The Latest Breaking News from Medical Daily

After years of public campaigning and parliamentary action, the NHS will formally include menopause in routine health assessments for adults aged 40–74. Campaigners say the change could improve quality of life for millions while reducing long-term risks such as osteoporosis and cardiovascular disease.

Authorities are investigating KISS guitarist Ace Frehley's death at age 74, with a toxicology report ordered after the rock icon was taken off life support following a brain bleed.

In the US, almost 90% of adults are affected by the CKM syndrome. But, what is it? Is it deadly? Here's what you should know about this condition.

Local support groups are assisting families that are struggling with sudden infant death syndrome (SIDS).

M&Y Care LLC understands that receiving care at home is becoming a preferred option for people seeking comfort, dignity, and personalized support in familiar surroundings.

A new study found that there are fewer children with peanut allergies in the last few years following a change in guidelines.

As Armin Ernst knows, forward-looking organizations are embracing digital transformation, building agile operating models, and fostering a culture of continuous learning. As the landscape continues to shift, adaptability and collaboration will prove essential for organizations that aim not just to grow, but to lead.

Nearly 80 percent of the world's poorest, or about 900 million people, are directly exposed to climate hazards exacerbated by global warming, bearing a "double and deeply unequal burden," the United Nations warned Friday.

Stellantis recalls nearly 300,000 Dodge Darts due to a gear shift issue that may cause rollaway accidents.

Ken was inspired to create the brand after witnessing his mother's struggles with unsuitable wheelchairs following surgery that left her unable to walk. Determined to change this, Ken founded Verpal—a brand dedicated to transforming wheelchairs from a burden into a trusted companion for everyday life.

AstraZeneca joins Pfizer in cutting US drug prices under Trump's new deal to offer lower costs for Medicaid patients.